MiniMed Group, Inc. Common Stock (MMED) is a publicly traded the market company. As of July 21, 2026, MMED trades at $17.30 with a market cap of $4.75B and a P/E ratio of -13.06. MMED moved +1.54% today. Year to date, MMED is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $10.65 to $20.48. Analyst consensus is strong buy with an average price target of $21.22. Rallies surfaces MMED's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for MMED combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $17.30 |
| Market Cap | $4.75B |
| P/E Ratio | -13.06 |
| EPS | $-1.30 |
| Dividend Yield | 0.00% |
| 52-Week High | $20.48 |
| 52-Week Low | $10.65 |
| Volume | 182.29K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.10B |
| Net Income | $-317.00M |
| Gross Margin | 54.16% |
11 analysts cover MMED: 0 strong buy, 10 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $21.22.